Cellid, Co., Ltd. (KOSDAQ:299660)
South Korea · Delayed Price · Currency is KRW 2,640.00
0.00 (0.00%)
At close: Mar 20, 2026
Cellid, Market Cap
Cellid, has a market cap or net worth of 77.89 billion as of March 20, 2026. Its market cap has decreased by -18.97% in one year.
Market Cap
77.89B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2,640.00
Market Cap Chart
Since February 20, 2019, Cellid,'s market cap has decreased from 482.44B to 77.89B, a decrease of -83.86%. That is a compound annual growth rate of -22.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 77.89B | -7.69% |
| Dec 30, 2025 | 84.38B | -20.98% |
| Dec 30, 2024 | 106.78B | 75.61% |
| Dec 28, 2023 | 60.81B | -46.82% |
| Dec 29, 2022 | 114.34B | -76.07% |
| Dec 30, 2021 | 477.80B | 21.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.27T |
| Celltrion | 45.86T |
| ALTEOGEN | 18.99T |
| Sam Chun Dang Pharm. | 18.23T |
| Oncocross | 84.88B |
| PharmGen Science | 82.06B |
| Ray Co., Ltd. | 80.51B |
| Enzychem Lifesciences | 78.33B |